华邦健康
(002004)
| 流通市值：98.12亿 | | | 总市值：103.15亿 |
| 流通股本：18.83亿 | | | 总股本：19.80亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,818,702,693.62 | 11,512,347,207.84 | 9,085,988,424.34 | 5,945,032,088.09 |
| 营业收入 | 2,818,702,693.62 | 11,512,347,207.84 | 9,085,988,424.34 | 5,945,032,088.09 |
| 二、营业总成本 | 2,516,630,644.28 | 10,357,705,761.77 | 8,097,647,440.81 | 5,353,287,909.61 |
| 营业成本 | 1,807,625,306.38 | 7,261,558,826.35 | 5,723,444,074.29 | 3,787,991,698.41 |
| 税金及附加 | 34,184,641.69 | 133,926,018.93 | 102,300,552.54 | 64,633,224.23 |
| 销售费用 | 270,091,149.77 | 1,127,296,200.71 | 967,485,254.24 | 679,396,280.23 |
| 管理费用 | 254,116,010.88 | 1,217,066,722.98 | 836,811,849.43 | 514,113,021.04 |
| 研发费用 | 76,271,189.09 | 341,616,761.85 | 281,993,931.22 | 197,547,094.89 |
| 财务费用 | 74,342,346.47 | 276,241,230.95 | 185,611,779.09 | 109,606,590.81 |
| 其中:利息费用 | 55,383,657.28 | 309,322,672.07 | 224,523,762.21 | 153,155,858.38 |
| 其中:利息收入 | 7,378,336.26 | 50,368,091.14 | 39,159,580.01 | 27,473,174.78 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -1,811,523.2 | 6,662,165.37 | 4,449,568.59 | 2,734,211.26 |
| 加:投资收益 | 19,368,252.16 | 60,323,670.48 | 21,877,855.3 | 45,604,511.88 |
| 资产处置收益 | 2,555,734.79 | 10,046,789.22 | 16,992,889.78 | 12,005,319.65 |
| 资产减值损失(新) | -3,944,680.78 | -185,872,182.51 | -7,999,859.19 | -8,094,961.01 |
| 信用减值损失(新) | -10,074,282.42 | -75,689,291.37 | -25,795,699.89 | -18,666,523.13 |
| 其他收益 | 13,754,360.92 | 76,473,226.67 | 63,204,742.36 | 41,348,739.98 |
| 四、营业利润 | 321,919,910.81 | 1,046,585,823.93 | 1,061,070,480.48 | 666,675,477.11 |
| 加:营业外收入 | 2,691,772.73 | 40,936,388.2 | 36,664,665.35 | 32,436,279.1 |
| 减:营业外支出 | 3,682,648.25 | 29,653,178.45 | 10,394,891.6 | 8,160,387.23 |
| 五、利润总额 | 320,929,035.29 | 1,057,869,033.68 | 1,087,340,254.23 | 690,951,368.98 |
| 减:所得税费用 | 80,016,403.95 | 176,635,761.25 | 207,905,855.11 | 141,077,981.82 |
| 六、净利润 | 240,912,631.34 | 881,233,272.43 | 879,434,399.12 | 549,873,387.16 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 240,912,631.34 | 881,233,272.43 | 879,434,399.12 | 549,873,387.16 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 154,832,474.27 | 713,188,344.47 | 611,820,373.56 | 388,455,625.5 |
| 少数股东损益 | 86,080,157.07 | 168,044,927.96 | 267,614,025.56 | 161,417,761.66 |
| 扣除非经常损益后的净利润 | 143,072,719.71 | 643,109,024.67 | 552,241,633.34 | 347,597,224.74 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.08 | 0.36 | 0.31 | 0.2 |
| (二)稀释每股收益 | 0.08 | 0.36 | 0.31 | 0.2 |
| 八、其他综合收益 | -13,450,188.44 | 19,220,275.54 | 24,148,295.85 | 34,835,443.96 |
| 归属于母公司股东的其他综合收益 | -6,257,657.32 | 15,429,559.73 | 11,114,458.08 | 16,380,915.78 |
| 九、综合收益总额 | 227,462,442.9 | 900,453,547.97 | 903,582,694.97 | 584,708,831.12 |
| 归属于母公司股东的综合收益总额 | 148,574,816.95 | 728,617,904.2 | 622,934,831.64 | 404,836,541.28 |
| 归属于少数股东的综合收益总额 | 78,887,625.95 | 171,835,643.77 | 280,647,863.33 | 179,872,289.84 |
| 公告日期 | 2026-04-25 | 2026-04-23 | 2025-10-29 | 2025-08-20 |
| 审计意见(境内) | | 标准无保留意见 | | |